Advertisement

Topics

First half underlying revenue increases for Smith & Nephew

05:24 EDT 28 Jul 2017 | SmartBrief

Smith & Nephew generated approximately $2.34 billion in underlying revenue during the first half of the year, a 3% increase.  -More

Original Article: First half underlying revenue increases for Smith & Nephew

NEXT ARTICLE

More From BioPortfolio on "First half underlying revenue increases for Smith & Nephew"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...